Production (Stage)
BiomX Inc.
PHGE
$0.511
-$0.0076-1.47%
AMEX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 15.36M | 14.79M | 12.26M | 11.16M | 9.85M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 37.26M | 35.55M | 32.31M | 29.58M | 25.18M |
Operating Income | -37.26M | -35.55M | -32.31M | -29.58M | -25.18M |
Income Before Tax | -8.05M | -17.71M | -8.69M | -26.23M | -37.11M |
Income Tax Expenses | 9.00K | 13.00K | 11.00K | 19.00K | 22.00K |
Earnings from Continuing Operations | -8.06 | -17.73 | -8.71 | -26.25 | -37.14 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -8.06M | -17.73M | -8.71M | -26.25M | -37.14M |
EBIT | -37.26M | -35.55M | -32.31M | -29.58M | -25.18M |
EBITDA | -35.45M | -33.75M | -31.22M | -28.59M | -24.31M |
EPS Basic | -0.05 | -2.50 | -2.61 | -4.23 | -6.23 |
Normalized Basic EPS | 0.13 | -1.33 | -1.68 | -2.89 | -3.82 |
EPS Diluted | -2.74 | -5.19 | -5.21 | -6.82 | -6.24 |
Normalized Diluted EPS | 0.05 | -1.41 | -1.76 | -2.97 | -3.82 |
Average Basic Shares Outstanding | 64.95M | 48.08M | 35.90M | 25.60M | 23.52M |
Average Diluted Shares Outstanding | 72.77M | 55.90M | 43.73M | 33.42M | 23.52M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |